1IntroductionIn this issue of the Scandinavian Journal of Pain Heinrich Wernze and Thomas Herdegen  report that spironolactone shows beneficial long-term effects on pain, mood, and quality of life in 50% of the 31 fibromyalgia patients they treated with spironolactone for 12 months. This review addresses two questions: why would spironolactone be effective in reducing fibromyalgia-related symptoms and what is the role of case series in modern medicine.2FibromyalgiaFibromyalgia is a common pain syndrome with a point prevalence of 1–5%. The majority of fibromyalgia patients are female. The syndrome is often preceded by local pain problems such as headache, neck and back pain, which then develop to widespread pain. Sleep disturbance and obesity are also related to fibromyalgia, which often coincides with other symptoms or diseases such as migraine, asthma, and irritable bowel disease. Anxiety and depression are common co-morbidities with fibromylgia as is the case with other chronic pain conditions. The pathophysiology of fibromyalgia is slowly being revealed. Dysfunction of the stress axis and descending pathways of endogenous pain inhibition, aberrant brain networks and peripheral small fibre neuropathy  have been shown to be related to fibromyalgia.The treatment of fibromyalgia consists of exercise, physiotherapy, and pharmacological management. However, the
Scandinavian Journal of Pain – de Gruyter
Published: Dec 29, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera